TLPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
TALPHERA, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.08+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $81.57M
- P/E (TTM)
- –
- Dividend yield
- –
TALPHERA, INC. balance sheet
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -1474700.0%
- Net margin
- -1507600.0%
- Return on equity, FY2025
- -114.2%
Financial strength
- Current ratio
- 4.29
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 17.7%
Valuation
- P/E ratio
- –
- Price to sales
- 81569.05
- Price to book
- 5.66
- Dividend yield
- –